Quantum eye test could catch blindness before it starts

NCT ID NCT05913063

Recruiting now Diagnosis Sponsor: Centre for Eye and Vision Research Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new device that uses special 'structured light' patterns to see if people with age-related macular degeneration (AMD) perceive them differently than those with healthy vision. The goal is to develop a test that can detect AMD earlier than current methods, before vision loss begins. Researchers will compare results from 50 participants, including those with AMD, glaucoma, and healthy controls.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Structured Light Imaging Microscopy (device)
What this could lead to: If successful, this could lead to a new, earlier way to diagnose age-related macular degeneration, potentially preventing vision loss.
What could go wrong: This is a small, early-stage study (50 people) testing a new device. It may not prove effective for diagnosis, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

age-related macular degeneration glaucoma macular degeneration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AGE-RELATED MACULAR DEGENERATION

Contacts and locations

Locations

Centre for Eye and Vision Research Limited
RECRUITING

Hong Kong, Guangdong, 00000, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.